RecruitingPhase 2ACTRN12612001051831

Intranasal white petrolatum versus chlorhexidine to reduce postoperative infections in dermatologic surgery

In patients scheduled for dermatologic surgery, is intranasal white petrolatum or chlorhexidine more effective than normal saline in reducing postoperative infections?


Sponsor

Eugene Tan

Enrollment

2,000 participants

Start Date

Sep 16, 2013

Study Type

Interventional

Conditions

Summary

New Zealand has the highest rate of skin cancers in the world which leads to a large number of skin excisions. About 30-40% of the population carry a bacterium known as Staphylococcus aureus. Carriage of this bacterium has been shown to increase the risk of surgical wound infections by up to eight times. Earlier studies have assessed the effectiveness of a topical antibiotic, mupirocin to eradicate carriage of Staphylococcus aureus. Unfortunately, this method has been complicated by bacterial resistance and allergic skin reactions. In this study, we want to see whether applying white petrolatum (Vaseline) or Chlorhexidine is effective for eradicating nasal carriage of staphylococcus aureus and reducing wound infections in dermatologic surgery. If proven to be effective, this simple method may be a safe and economic method to reduce the incidence of wound infections in dermatologic surgery.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Inclusion Criteria1

  • Patients scheduled for elective dermatologic surgery for removal of skin cancer.

Exclusion Criteria4

  • Current infection
  • Current antibiotic therapy
  • Antibiotic use in the last month
  • Failure to have intranasal swab to assess carriage of S. aureus prior to surgery

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Referrals to the Skin Centre for excision of skin cancers will be selected for possible inclusion by one of five participating Consultant Dermatologists. Eligible and consenting patients will at the t

Referrals to the Skin Centre for excision of skin cancers will be selected for possible inclusion by one of five participating Consultant Dermatologists. Eligible and consenting patients will at the time of consultation for surgery, fill in a short questionnaire for demographic data and have a nasal swab to assess staphylococcus aureus carriage. The patients will be randomised to either intranasal white petrolatum, 2% chlorhexidine or normal saline to the anterior nares. Five days prior to elective surgery, all patients will apply one of three treatments (depending on randomisation) to the anterior nares twice daily. In the chlorhexidine arm and the normal saline arm, this will be in the manner of a soaked cotton bud whereas in the white petrolatum arm, this will be in the manner of a cotton bud application. All patients will have their wound assessed at the time of suture removal (expected range: 5 – 14 days depending on type of surgery) or if any clinical signs of wound infection occur outside this time frame (up to one month post-surgery). All infected wounds will be swabbed. The incidence of wound infection will be collected and a comparison will be made to the incidence of wound infection in patients being treated with intranasal white petrolatum, 2% chlorhexidine and individuals using intranasal normal saline.


Locations(1)

Bay of Plenty, New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12612001051831


Related Trials